Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvette Robbins

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Cancer Cell|April 14, 2023
Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancerCem Sievers, Marco Craveiro, Jay Friedman, et al.
Journal for Immunotherapy of Cancer|May 23, 2020
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populationsKellsye P Fabian, Michelle R Padget, Renee N Donahue, et al.
Cancers|February 25, 2023
Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous CarcinomaTiffany Toni, Ramya Viswanathan, Yvette Robbins, et al.
Journal for Immunotherapy of Cancer|August 31, 2021
Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosisYvette Robbins, Jay Friedman, Paul E Clavijo, et al.
Cell Death and Differentiation|April 13, 2023
Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC)Ethan L Morgan, Tiffany Toni, Ramya Viswanathan, et al.
Science Translational Medicine|October 25, 2023
The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosisScott M Norberg, Ke Bai, Cem Sievers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2019
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer ModelsSarah Greene, Yvette Robbins, Wojciech K Mydlarz, et al.
JCI Insight|April 5, 2019
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapyLillian Sun, Paul E Clavijo, Yvette Robbins, et al.
Journal for Immunotherapy of Cancer|March 20, 2021
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cellsMaxwell Y Lee, Yvette Robbins, Cem Sievers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2019
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T CellsJay Friedman, Ellen C Moore, Paul Zolkind, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cancer Cell|April 14, 2023
Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancerCem Sievers, Marco Craveiro, Jay Friedman, et al.
Journal for Immunotherapy of Cancer|May 23, 2020
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populationsKellsye P Fabian, Michelle R Padget, Renee N Donahue, et al.
Cancers|February 25, 2023
Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous CarcinomaTiffany Toni, Ramya Viswanathan, Yvette Robbins, et al.
Journal for Immunotherapy of Cancer|August 31, 2021
Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosisYvette Robbins, Jay Friedman, Paul E Clavijo, et al.
Cell Death and Differentiation|April 13, 2023
Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC)Ethan L Morgan, Tiffany Toni, Ramya Viswanathan, et al.
Science Translational Medicine|October 25, 2023
The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosisScott M Norberg, Ke Bai, Cem Sievers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2019
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer ModelsSarah Greene, Yvette Robbins, Wojciech K Mydlarz, et al.
JCI Insight|April 5, 2019
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapyLillian Sun, Paul E Clavijo, Yvette Robbins, et al.
Journal for Immunotherapy of Cancer|March 20, 2021
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cellsMaxwell Y Lee, Yvette Robbins, Cem Sievers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2019
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T CellsJay Friedman, Ellen C Moore, Paul Zolkind, et al.
Pageof 3